S Salpietro

Summary

Affiliation: University of Modena and Reggio Emilia
Country: Italy

Publications

  1. ncbi Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study
    C Mussini
    Dept of Infectious Diseases, Policlinico, University of Modena and Reggio Emilio Hospital, 41100 Modena, Italy
    J Infect Dis 181:1635-42. 2000
  2. ncbi Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption
    Cristina Mussini
    Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy
    J Acquir Immune Defic Syndr 52:588-94. 2009
  3. ncbi Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, and Azienda Policlinico, Modena, Italy
    AIDS 22:2461-9. 2008
  4. ncbi Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 19:1627-33. 2005
  5. ncbi Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy
    Clin Infect Dis 38:565-71. 2004
  6. ncbi Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliera Policlinico, University of Modena and Reggio Emilia, Modena, Italy
    Clin Infect Dis 36:645-51. 2003
  7. ncbi An observational study on patients treated or not for acute HIV infection
    C Mussini
    Clinic of Infectious Diseases, Policlinico and University of Modena and Reggio Emilia, Italy
    J Biol Regul Homeost Agents 16:79-82. 2002
  8. ncbi Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis
    Antonella d'Arminio Monforte
    Clinic of Infectious and Tropical Diseases, Dept of Medicine, Surgery and Dentistry, San Paolo Hospital, University of Milan, via A Di Rudinì 8 20142, Milan, Italy
    Clin Infect Dis 49:612-22. 2009
  9. ncbi Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008
    M C F Prosperi
    Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy
    HIV Med 12:174-82. 2011
  10. ncbi Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count
    Giulia Marchetti
    Department of Medicine, Surgery and Dentistry, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Italy
    AIDS 25:1385-94. 2011

Collaborators

Detail Information

Publications10

  1. ncbi Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study
    C Mussini
    Dept of Infectious Diseases, Policlinico, University of Modena and Reggio Emilio Hospital, 41100 Modena, Italy
    J Infect Dis 181:1635-42. 2000
    ..The results of this study strongly indicate that primary prophylaxis for P. carinii pneumonia and toxoplasmic encephalitis can be safely discontinued in patients whose CD4+ T cell counts increase to >200 cells/mm3 during HAART...
  2. ncbi Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption
    Cristina Mussini
    Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy
    J Acquir Immune Defic Syndr 52:588-94. 2009
    ..The extent of immune reconstitution following HAART resumption after 1 cycle of treatment interruption (TI) is not well known...
  3. ncbi Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, and Azienda Policlinico, Modena, Italy
    AIDS 22:2461-9. 2008
    ..Many patients infected with HIV still present with an AIDS diagnosis. The aim of this study was to evaluate the virological, immunological and clinical outcomes of HAART in these patients...
  4. ncbi Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 19:1627-33. 2005
    ..HIV infection per se and HAART can alter mitochondrial functionality, leading to a decrease in mitochondrial DNA content...
  5. ncbi Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy
    Clin Infect Dis 38:565-71. 2004
    ..Recurrent cryptococcal infection should be suspected in patients whose serum cryptococcal antigen test results revert back to positive after discontinuation of maintenance therapy...
  6. ncbi Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliera Policlinico, University of Modena and Reggio Emilia, Modena, Italy
    Clin Infect Dis 36:645-51. 2003
    ..Patients who present with symptoms after discontinuation of secondary prophylaxis should be evaluated for PCP despite high CD4 count and complete virus suppression...
  7. ncbi An observational study on patients treated or not for acute HIV infection
    C Mussini
    Clinic of Infectious Diseases, Policlinico and University of Modena and Reggio Emilia, Italy
    J Biol Regul Homeost Agents 16:79-82. 2002
    ..Open questions are how can we identify patients who will be slow progressors or long-term non progressors, and, as a consequence, do not require treatment...
  8. ncbi Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis
    Antonella d'Arminio Monforte
    Clinic of Infectious and Tropical Diseases, Dept of Medicine, Surgery and Dentistry, San Paolo Hospital, University of Milan, via A Di Rudinì 8 20142, Milan, Italy
    Clin Infect Dis 49:612-22. 2009
    ..We evaluated the correlation between the occurrence of different AIDS-defining illnesses (ADIs) and chronic HCV infection or HCV-related liver cirrhosis in a large Italian cohort of human immunodeficiency virus (HIV)-infected subjects...
  9. ncbi Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008
    M C F Prosperi
    Clinic of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy
    HIV Med 12:174-82. 2011
    ....
  10. ncbi Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count
    Giulia Marchetti
    Department of Medicine, Surgery and Dentistry, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Italy
    AIDS 25:1385-94. 2011
    ..We investigated the significance of microbial translocation measured on average 3 years after HIV seroconversion in driving disease progression in HIV untreated patients with high CD4(+) cell count...